Physician profile
Evan R Eisenberg
NPI 1750315883
$6,793.19
in general payments reported to CMS, 2019-2025
54 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $344 · 2021: $860 · 2022: $1,230 · 2023: $1,160 · 2024: $746 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,011 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,010.99 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $812.88 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $662.11 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $508.51 | 2019-2025 | Provenge |
| Pfizer INC. | $405.01 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $398.03 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $302.92 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $251.18 | 2019-2025 | |
| Antares Pharma, INC. | $240.15 | 2019-2024 | Xyosted |
| Progenics Pharmaceuticals, INC. | $188.62 | 2021-2025 | Pylarify |
| Teleflex LLC | $178.97 | 2022-2025 | Urolift |
| Endo USA, INC. | $172.27 | 2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $168.04 | 2019-2023 | Xiaflex, Aveed |
| Verity Pharmaceuticals INC. | $161.46 | 2023-2025 | Trelstar |
| Amgen INC. | $147.15 | 2019-2023 | Xgeva |
| Medtronic USA, INC. | $144.21 | 2020 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Eisenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.